1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Reduction in Volume of Nucleus Basalis of Meynert Is Specific to Parkinson’s Disease and Progressive Supranuclear Palsy but Not to Multiple System Atrophy
(
- Contribution to journal › Article
- 2017
-
Mark
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
(
- Contribution to journal › Scientific review
-
Mark
Clinical diagnosis of progressive supranuclear palsy : The movement disorder society criteria
(
- Contribution to journal › Article
- 2012
-
Mark
Neuregulin-1 receptor tyrosine kinase ErbB4 is upregulated in midbrain dopaminergic neurons in Parkinson disease
(
- Contribution to journal › Article
-
Mark
Serotonin Neuron Loss and Nonmotor Symptoms Continue in Parkinson's Patients Treated with Dopamine Grafts
(
- Contribution to journal › Article
- 2011
-
Mark
Graft-Induced Dyskinesias in Parkinson's Disease: High Striatal Serotonin/Dopamine Transporter Ratio
(
- Contribution to journal › Article
-
Mark
Systemic administration of Neuregulin-1ß(1) protects dopaminergic neurons in a mouse model of Parkinson's disease.
(
- Contribution to journal › Article
- 2008
-
Mark
Deep brain stimulation in Parkinson's disease following fetal nigral transplantation
(
- Contribution to journal › Article
- 2002
-
Mark
Dyskinesias following neural transplantation in Parkinson's disease.
(
- Contribution to journal › Article